复发性子宫内膜异位症的诊治新进展

doi:10.12280/gjfckx.20220724

摘要/Abstract

摘要：

子宫内膜异位症（endometriosis，EMs）存在盆腔粘连解剖关系异常、病灶隐匿清除不尽、术野界限不清等问题。经手术和规范药物治疗后症状消失或缓解并持续半年后，再次出现临床症状且恢复到治疗前水平或加重，称为复发性EMs。复发性EMs的病因尚不明确，虽然初次手术的彻底性和规范用药可减少复发，但临床中仍存在较多难治性病例。基于疾病的复杂性及不确定性，综合考虑患者卵巢功能、排除恶变及预防再复发等因素，寻找最佳治疗方案是目前亟待解决的关键问题。综述复发性EMs的诊治新进展，为选择最佳的治疗方案提供重要依据。

关键词: 子宫内膜异位症, 复发, 药物疗法, 妇科外科手术, 诊断

Abstract:

Endometriosis (EMs) suffers from abnormal anatomical relationship of pelvic adhesions, incomplete removal of occult lesions, and unclear surgical field boundaries. After surgery and standard drug treatment, the symptoms eliminate or alleviate for half a year. After that, the clinical symptoms reappear and return to the pre-treatment level or aggravate, which is called recurrent EMs. The etiology of recurrent EMs is still unclear. Although the thoroughness of the initial surgery and standardized medication can reduce recurrence, there are still many refractory cases in clinic. Based on the complexity and uncertainty of the disease, comprehensive consideration of patients with ovarian function, eliminate malignant and prevent recurrence and other factors, to find the best treatment is the key issues to be resolved. This article aims to review the new progress in the diagnosis and treatment of recurrent EMs and provide an important basis for selecting the best treatment options.

Key words: Endometriosis, Recurrence, Drug therapy, Gynecologic surgical procedures, Diagnosis

张琪, 倪妍. 复发性子宫内膜异位症的诊治新进展[J]. 国际妇产科学杂志, 2023, 50(1): 98-101.

ZHANG Qi, NI Yan. New Progress in Diagnosis and Treatment of Recurrent Endometriosis[J]. Journal of International Obstetrics and Gynecology, 2023, 50(1): 98-101.

参考文献 31

[1]	冷金花, 史精华. 子宫内膜异位症复发的高危因素及其防治策略[J]. 中华妇产科杂志, 2018, 53(9):640-643. doi: 10.3760/cma.j.issn.0529-567x.2018.09.013. doi: 10.3760/cma.j.issn.0529-567x.2018.09.013
[2]	Ianieri MM, Mautone D, Ceccaroni M. Recurrence in Deep Infiltrating Endometriosis: A Systematic Review of the Literature[J]. J Minim Invasive Gynecol, 2018, 25(5):786-793. doi: 10.1016/j.jmig.2017.12.025. doi: 10.1016/j.jmig.2017.12.025
[3]	Guo SW, Martin DC. The perioperative period: a critical yet neglected time window for reducing the recurrence risk of endometriosis?[J]. Hum Reprod, 2019, 34(10):1858-1865. doi: 10.1093/humrep/dez187. doi: 10.1093/humrep/dez187
[4]	郎景和. 对子宫内膜异位症认识的历史、现状与发展[J]. 中国实用妇科与产科杂志, 2020, 36(3):193-196. doi: 10.19538/j.fk2020030101. doi: 10.19538/j.fk2020030101
[5]	Lee N, Min S, Won S, et al. The recurrence rate of ovarian endometrioma in women aged 40-49 years and impact of hormonal treatment after conservative surgery[J]. Sci Rep, 2020, 10(1):16461. doi: 10.1038/s41598-020-73434-0. doi: 10.1038/s41598-020-73434-0
[6]	Busacca M, Chiaffarino F, Candiani M, et al. Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis[J]. Am J Obstet Gynecol, 2006, 195(2):426-432. doi: 10.1016/j.ajog.2006.01.078. doi: 10.1016/j.ajog.2006.01.078 pmid: 16890551
[7]	Tarumi Y, Mori T, Shimura K, et al. Progesterone Receptor Status of Epithelial Cells as a Predictive Marker for Postoperative Recurrence of Endometriosis[J]. J Clin Endocrinol Metab, 2022, 107(6):1552-1559. doi: 10.1210/clinem/dgac118. doi: 10.1210/clinem/dgac118
[8]	Liu S, Xin W, Tang X, et al. LncRNA H19 Overexpression in Endometriosis and its Utility as a Novel Biomarker for Predicting Recurrence[J]. Reprod Sci, 2020, 27(9):1687-1697. doi: 10.1007/s43032-019-00129-x. doi: 10.1007/s43032-019-00129-x pmid: 32468268
[9]	Jayakumaran J, Pavlovic Z, Fuhrich D, et al. Robotic single-site endometriosis resection using near-infrared fluorescence imaging with indocyanine green: a prospective case series and review of literature[J]. J Robot Surg, 2020, 14(1):145-154. doi: 10.1007/s11701-019-00951-0. doi: 10.1007/s11701-019-00951-0 pmid: 30937836
[10]	Liu X, Yuan L, Shen F, et al. Patterns of and risk factors for recurrence in women with ovarian endometriomas[J]. Obstet Gynecol, 2007, 109(6):1411-1420. doi: 10.1097/01.AOG.0000265215.87717.8b. doi: 10.1097/01.AOG.0000265215.87717.8b pmid: 17540815
[11]	Canis M, Bourdel N, Chauvet P, et al. Recurrences of endometriosis after surgery may be the consequence of retrograde menstruation on the postoperative scar[J]. Hum Reprod, 2020, 35(5):1246-1247. doi: 10.1093/humrep/deaa053. doi: 10.1093/humrep/deaa053
[12]	Donnez J, Dolmans MM. Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review[J]. J Clin Med, 2021, 10(5):1085. doi: 10.3390/jcm10051085. doi: 10.3390/jcm10051085
[13]	徐冰, 李华军, 贾婉璐, 等. 地诺孕素用于难治性子宫内膜异位症疼痛的临床研究[J]. 中华妇产科杂志, 2021, 56(3):178-184. doi: 10.3760/cma.j.cn112141-20200525-00444. doi: 10.3760/cma.j.cn112141-20200525-00444
[14]	Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis[J]. Hum Reprod Open, 2022, 2022(2): hoac009. doi: 10.1093/hropen/hoac009. doi: 10.1093/hropen/hoac009
[15]	Bouquet de Joliniere J, Fruscalzo A, Khomsi F, et al. Antiangiogenic Therapy as a New Strategy in the Treatment of Endometriosis? The First Case Report[J]. Front Surg, 2021, 8:791686. doi: 10.3389/fsurg.2021.791686. doi: 10.3389/fsurg.2021.791686
[16]	Miller LE, Bhattacharyya R, Miller VM. Clinical Utility of Presacral Neurectomy as an Adjunct to Conservative Endometriosis Surgery: Systematic Review and Meta-Analysis of Controlled Studies[J]. Sci Rep, 2020, 10(1):6901. doi: 10.1038/s41598-020-63966-w. doi: 10.1038/s41598-020-63966-w pmid: 32327689
[17]	Abesadze E, Sehouli J, Mechsner S, et al. Possible Role of the Posterior Compartment Peritonectomy, as a Part of the Complex Surgery, Regarding Recurrence Rate, Improvement of Symptoms and Fertility Rate in Patients with Endometriosis, Long-Term Follow-Up[J]. J Minim Invasive Gynecol, 2020, 27(5):1103-1111. doi: 10.1016/j.jmig.2019.08.019. doi: 10.1016/j.jmig.2019.08.019
[18]	Prabhu AV, Schad MD, Burnett AF, et al. Radiation treatment for refractory endometriosis: a 38-year-old female presenting with vaginal bleeding[J]. Rep Pract Oncol Radiother, 2021, 26(3):457-462. doi: 10.5603/RPOR.a2021.0057. doi: 10.5603/RPOR.a2021.0057
[19]	Alborzi S, Askary E, Keramati P, et al. Assisted reproductive technique outcomes in patients with endometrioma undergoing sclerotherapy vs laparoscopic cystectomy: Prospective cross-sectional study[J]. Reprod Med Biol, 2021, 20(3):313-320. doi: 10.1002/rmb2.12386. doi: 10.1002/rmb2.12386 pmid: 34262399
[20]	De Cicco Nardone A, Carfagna P, De Cicco Nardone C, et al. Laparoscopic Ethanol Sclerotherapy for Ovarian Endometriomas: Preliminary Results[J]. J Minim Invasive Gynecol, 2020, 27(6):1331-1336. doi: 10.1016/j.jmig.2019.09.792. doi: 10.1016/j.jmig.2019.09.792
[21]	彭超, 周应芳. 复发性卵巢子宫内膜异位症的管理[J]. 中国实用妇科与产科杂志, 2022, 38(5):491-495. doi: 10.19538/j.fk2022050104. doi: 10.19538/j.fk2022050104
[22]	Schweppe KW, Ring D. Peritoneal defects and the development of endometriosis in relation to the timing of endoscopic surgery during the menstrual cycle[J]. Fertil Steril, 2002, 78(4):763-766. doi: 10.1016/s0015-0282(02)03431-3. doi: 10.1016/s0015-0282(02)03431-3
[23]	Guo SW, Martin DC. Reply: Perioperative intervention vs. postoperative menstruation suppression in preventing recurrence of endometriosis[J]. Hum Reprod, 2020, 35(5):1247-1248. doi: 10.1093/humrep/deaa054. doi: 10.1093/humrep/deaa054
[24]	Hur C, Falcone T. Robotic treatment of bowel endometriosis[J]. Best Pract Res Clin Obstet Gynaecol, 2021, 71:129-143. doi: 10.1016/j.bpobgyn.2020.05.012. doi: 10.1016/j.bpobgyn.2020.05.012 pmid: 32684433
[25]	Bourdel N, Jaillet L, Bar-Shavit Y, et al. Indocyanine green in deep infiltrating endometriosis: a preliminary feasibility study to examine vascularization after rectal shaving[J]. Fertil Steril, 2020, 114(2):367-373. doi: 10.1016/j.fertnstert.2020.03.042. doi: S0015-0282(20)30329-0 pmid: 32646588
[26]	Moses AS, Demessie AA, Taratula O, et al. Nanomedicines for Endometriosis: Lessons Learned from Cancer Research[J]. Small, 2021, 17(7):e2004975. doi: 10.1002/smll.202004975. doi: 10.1002/smll.202004975
[27]	贾志红, 倪妍. 输尿管子宫内膜异位症的诊断及治疗进展[J]. 中国妇产科临床杂志, 2022, 23(1):106-108. doi: 10.13390/j.issn.1672-1861.2022.01.040. doi: 10.13390/j.issn.1672-1861.2022.01.040
[28]	Cunha F, Arcoverde F, Andres MP, et al. Laparoscopic Treatment of Ureteral Endometriosis: A Systematic Review[J]. J Minim Invasive Gynecol, 2021, 28(4):779-787. doi: 10.1016/j.jmig.2020.11.022. doi: 10.1016/j.jmig.2020.11.022
[29]	Vitral G, Salgado HC, Rangel J. Use of radioguided surgery in abdominal wall endometriosis: An innovative approach[J]. World J Nucl Med, 2018, 17(3):204-206. doi: 10.4103/wjnm.WJNM_47_17. doi: 10.4103/wjnm.WJNM_47_17 pmid: 30034288
[30]	梁炎春, 廖丹, 韦雅婧, 等. 吲哚菁绿荧光显影应用于腹壁子宫内膜异位症切除术中的初步探讨[J]. 中华妇产科杂志, 2021, 56(12):849-855. doi: 10.3760/cma.j.cn112141-20210919-00533. doi: 10.3760/cma.j.cn112141-20210919-00533
[31]	Maier IM, Maier AC, Crişan A, et al. Clinical and Pathological Significance of Cellular Atypia in Endometriosis[J]. Medicina (Kaunas), 2021, 57(5):453. doi: 10.3390/medicina57050453. doi: 10.3390/medicina57050453